Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system - PubMed (original) (raw)
. 1996 Oct 1;93(20):10662-7.
doi: 10.1073/pnas.93.20.10662.
A Yamamoto, K Furukawa, S Yamashiro, M Shin, M Okada, S Fukumoto, M Haraguchi, N Takeda, K Fujimura, M Sakae, M Kishikawa, H Shiku, K Furukawa, S Aizawa
Affiliations
- PMID: 8855236
- PMCID: PMC38211
- DOI: 10.1073/pnas.93.20.10662
Mice with disrupted GM2/GD2 synthase gene lack complex gangliosides but exhibit only subtle defects in their nervous system
K Takamiya et al. Proc Natl Acad Sci U S A. 1996.
Abstract
Gangliosides, sialic acid-containing glycosphingolipids, are abundant in the vertebrate (mammalian) nervous system. Their composition is spatially and developmentally regulated, and gangliosides have been widely believed to lay essential roles in establishment of the nervous system, especially in neuritogenesis and synaptogenesis. However, this has never been tested directly. Here we report the generation of mice with a disrupted beta 1,4-N-acetylgalactosaminyltransferase (GM2/GD2 synthase; EC 2.4.1.92) gene. The mice lacked all complex gangliosides. Nevertheless, they did not show any major histological defects in their nervous systems or in gross behavior. Just a slight reduction in the neural conduction velocity from the tibial nerve to the somatosensory cortex, but not to the lumbar spine, was detected. These findings suggest that complex gangliosides are required in neuronal functions but not in the morphogenesis and organogenesis of the brain. The higher levels of GM3 and GD3 expressed in the brains of these mutant mice may be able to compensate for the lack of complex gangliosides.
Similar articles
- Mice lacking complex gangliosides develop Wallerian degeneration and myelination defects.
Sheikh KA, Sun J, Liu Y, Kawai H, Crawford TO, Proia RL, Griffin JW, Schnaar RL. Sheikh KA, et al. Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7532-7. doi: 10.1073/pnas.96.13.7532. Proc Natl Acad Sci U S A. 1999. PMID: 10377449 Free PMC article. - A functional role for complex gangliosides: motor deficits in GM2/GD2 synthase knockout mice.
Chiavegatto S, Sun J, Nelson RJ, Schnaar RL. Chiavegatto S, et al. Exp Neurol. 2000 Dec;166(2):227-34. doi: 10.1006/exnr.2000.7504. Exp Neurol. 2000. PMID: 11085888 - Beta1,4-N-acetylgalactosaminyltransferase--GM2/GD2 synthase: a key enzyme to control the synthesis of brain-enriched complex gangliosides.
Furukawa K, Takamiya K, Furukawa K. Furukawa K, et al. Biochim Biophys Acta. 2002 Dec 19;1573(3):356-62. doi: 10.1016/s0304-4165(02)00403-8. Biochim Biophys Acta. 2002. PMID: 12417418 Review. - Neuromuscular synaptic transmission in aged ganglioside-deficient mice.
Zitman FM, Todorov B, Verschuuren JJ, Jacobs BC, Furukawa K, Furukawa K, Willison HJ, Plomp JJ. Zitman FM, et al. Neurobiol Aging. 2011 Jan;32(1):157-67. doi: 10.1016/j.neurobiolaging.2009.01.007. Epub 2009 Feb 23. Neurobiol Aging. 2011. PMID: 19233512 - Disordered testosterone transport in mice lacking the ganglioside GM2/GD2 synthase gene.
Furukawa K, Takamiya K, Ohmi Y, Bhuiyan RH, Tajima O, Furukawa K. Furukawa K, et al. FEBS Open Bio. 2023 Sep;13(9):1615-1624. doi: 10.1002/2211-5463.13603. Epub 2023 Apr 6. FEBS Open Bio. 2023. PMID: 36999634 Free PMC article. Review.
Cited by
- Age-Related Effects of Inhalational Anesthetics in _B4galnt1_-Null and Cuprizone-Treated Mice: Clinically Relevant Insights into Demyelinating Diseases.
Tot OK, Mrđenović S, Ivić V, Rončević R, Milić J, Viljetić B, Heffer M. Tot OK, et al. Curr Issues Mol Biol. 2024 Aug 1;46(8):8376-8394. doi: 10.3390/cimb46080494. Curr Issues Mol Biol. 2024. PMID: 39194711 Free PMC article. - Functional evaluation of novel variants of B4GALNT1 in a patient with hereditary spastic paraplegia and the general population.
Inamori KI, Nakamura K, Shishido F, Hsu JC, Nagafuku M, Nitta T, Ikeda J, Yoshimura H, Kodaira M, Tsuchida N, Matsumoto N, Uemura S, Ohno S, Manabe N, Yamaguchi Y, Togayachi A, Aoki-Kinoshita KF, Nishihara S, Furukawa JI, Kaname T, Nakamura M, Shimohata T, Tadaka S, Shirota M, Kinoshita K, Nakamura Y, Ohno I, Sekijima Y, Inokuchi JI. Inamori KI, et al. Front Neurosci. 2024 Jul 31;18:1437668. doi: 10.3389/fnins.2024.1437668. eCollection 2024. Front Neurosci. 2024. PMID: 39145292 Free PMC article. - Glycosphingolipids in Osteoarthritis and Cartilage-Regeneration Therapy: Mechanisms and Therapeutic Prospects Based on a Narrative Review of the Literature.
Homan K, Onodera T, Matsuoka M, Iwasaki N. Homan K, et al. Int J Mol Sci. 2024 Apr 30;25(9):4890. doi: 10.3390/ijms25094890. Int J Mol Sci. 2024. PMID: 38732111 Free PMC article. Review. - Gangliosides as Therapeutic Targets for Neurodegenerative Diseases.
Inci OK, Basırlı H, Can M, Yanbul S, Seyrantepe V. Inci OK, et al. J Lipids. 2024 Apr 8;2024:4530255. doi: 10.1155/2024/4530255. eCollection 2024. J Lipids. 2024. PMID: 38623278 Free PMC article. Review. - Lipid Rafts: The Maestros of Normal Brain Development.
Viljetić B, Blažetić S, Labak I, Ivić V, Zjalić M, Heffer M, Balog M. Viljetić B, et al. Biomolecules. 2024 Mar 18;14(3):362. doi: 10.3390/biom14030362. Biomolecules. 2024. PMID: 38540780 Free PMC article. Review.
References
- Pharmacol Biochem Behav. 1982 Dec;17(6):1251-6 - PubMed
- Cancer Res. 1989 Nov 15;49(22):6258-64 - PubMed
- J Neurosci Res. 1984;12(2-3):245-55 - PubMed
- J Biol Chem. 1989 Oct 25;264(30):17615-8 - PubMed
- Brain Res. 1990 Jan 8;506(2):291-3 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases